Walter Newman

机构：Leap Therapeutics, Inc. (United States) · ORCID：0000-0001-6428-0302

发表论文 168 篇 · 总被引 19152 次 · h-index 55

代表论文

mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment (2020 · Molecular Cancer Research · 被引 72)
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer (2020 · JCO Precision Oncology · 被引 63)
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors (2022 · Clinical Cancer Research · 被引 50)
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN ‐01 (2022 · Liver International · 被引 22)
Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors (2021 · Scientific Reports · 被引 16)
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism (2022 · Science Advances · 被引 15)